Format

Send to

Choose Destination
Cancer. 2015 May 1;121(9):1347-56. doi: 10.1002/cncr.29222. Epub 2015 Jan 13.

Screening and early detection efforts in lung cancer.

Author information

1
Department of Medicine, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston, South Carolina.

Abstract

Lung cancer is the leading cause of cancer-related death in the United States. Since publication of results from the National Lung Screening Trial, several professional organizations, including the US Preventive Services Task Force, have published guidelines recommending low-dose computed tomography for screening in asymptomatic, high-risk individuals. The benefits of screening include detection of cancer at an early stage when a definitive cure is possible, but the risks include overdiagnosis, false-positive results, psychological distress, and radiation exposure. The current review covers the scope of low-dose computed tomography screening, potential risks, costs, and future directions in the efforts for early detection of lung cancer.

KEYWORDS:

cancer screening; early detection; lung neoplasms; risk assessment

PMID:
25641734
DOI:
10.1002/cncr.29222
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center